探討Anti-CTLA-4抗體加劇自體免疫腦下垂體炎的機制與評估CTLA-4Ig 重組蛋白治療自體免疫腦下垂體炎的效果

Full metadata record

DC Field	Value	Language
dc.contributor.author	鄒協成	zh_TW
dc.contributor.author	Tzou Shey-Cherng	en_US
dc.date.accessioned	2016-03-28T08:17:29Z	-
dc.date.available	2016-03-28T08:17:29Z	-
dc.date.issued	2015	en_US
dc.identifier.govdoc	MOST104-2320-B009-006	zh_TW
dc.identifier.uri	http://hdl.handle.net/11536/130077	-
dc.identifier.uri	https://www.grb.gov.tw/search/planDetail?id=11568699&docId=467923	en_US
dc.description.sponsorship	科技部	zh_TW
dc.language.iso	zh_TW	en_US
dc.title	探討Anti-CTLA-4抗體加劇自體免疫腦下垂體炎的機制與評估CTLA-4Ig 重組蛋白治療自體免疫腦下垂體炎的效果	zh_TW
dc.title	Investigation of How Anti-CTLA-4 Antibody Exacerbates Autoimmune Hypophysitis and Evaluation of Whether Recombinant CTLA-4Ig Can Treat Autoimmune Hypophysitis	en_US
dc.type	Plan	en_US
dc.contributor.department	國立交通大學生物科技學系（所）	zh_TW
Appears in Collections:	Research Plans